dQ&A's latest diabetes research includes two presentations from our team at ATTD 2026, one of the world's leading stages for diabetes advancements.
Our hearts are heavy at the pain felt by the Black community. We are committed to working towards a more equitable future, and we invite you to join us.
Our third COVID-19 survey of U.S. diabetes patients found high infection concern, income loss, care changes, and challenges accessing healthy food and supplies.
dQ&A analyzes telemedicine diabetes care during COVID-19—trends, patient experiences, and what's next for virtual visits amid evolving healthcare needs.
Our survey of Canada’s type 1 diabetes community reveals COVID-19’s impact on medication access, diet, exercise, hyperglycemia, and overall well-being.
Our April 2020 dQ&A survey of 4,700 U.S. diabetes patients finds supply chains largely intact yet short-term delays and risky pharmacy visits hinder refills.
Our second COVID-19 impact survey of 4,500+ U.S. diabetes patients found ongoing drug/supply delays, care disruptions, and declines in diet and exercise.
Our study of US patients explores insulin rationing’s physical & emotional impact through qualitative & quantitative research. Check out the community video.
This survey explores the impact of COVID-19 on diabetes management, revealing high concern, precautionary steps, and changes in work and daily routines.
